Noninvasive Computed Tomography-Based Quantification of Tumor Fibrosis Predicts Pancreatic Cancer Response to Gemcitabine/Nab-Paclitaxel

Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis. Chemotherapy remains the mainstay for unresectable cases, yet regimens like AG (gemcitabine/nab-paclitaxel) exhibit heterogeneous efficacy. Tumor fibrosis has emerged as a potential predictor of treatment response but lacks validate...

Full description

Bibliographic Details

Published in:	Research
Main Authors:	Qiuxia Yang, Yize Mao, Yulong Han, Kailai Li, Wanming Hu, Jianyao Zhou, Xuejun Gong, Shuxiang Huang, Rong Zhang, Lizhi Liu, Ningning Niu, Yixiong Li, Liandong Ji, Xiaoping Yi, Wufeng Xue, Dong Ni, Wenjun Mao, Peng Luo, Dong Luo, Jun Cheng
Format:	Article
Language:	English
Published:	American Association for the Advancement of Science (AAAS) 2025-01-01
Online Access:	https://spj.science.org/doi/10.34133/research.0937